Viewing Study NCT00642018


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-01-22 @ 9:23 AM
Study NCT ID: NCT00642018
Status: COMPLETED
Last Update Posted: 2019-04-03
First Post: 2008-02-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hormone Refractory Prostate Cancer View